Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Clinical benefit of ixazomib plus lenalidomide‐dexamethasone in myeloma patients with non‐canonical NF‐κB pathway activation.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Dash, Ajeeta B.1 (AUTHOR) ; Zhang, Jacob1 (AUTHOR); Shen, Lei1 (AUTHOR); Li, Bin1 (AUTHOR); Berg, Deborah1 (AUTHOR); Lin, Jianchang1 (AUTHOR); Avet‐Loiseau, Hervé2 (AUTHOR); Bahlis, Nizar J.3 (AUTHOR); Moreau, Philippe4 (AUTHOR); Richardson, Paul G.5 (AUTHOR); Di Bacco, Alessandra1 (AUTHOR)
- المصدر:
European Journal of Haematology. Sep2020, Vol. 105 Issue 3, p274-285. 12p.
No Comments.